The protective role of shenqi compound in type 2 diabetes: A comprehensive investigation of pancreatic β-cell function and mass-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

The protective role of shenqi compound in type 2 diabetes: A comprehensive investigation of pancreatic β-cell function and mass

Published:2023-10 Issue: Volume:166 Page:115287
ISSN:0753-3322
Container-title:Biomedicine & Pharmacotherapy
language:en
Short-container-title:Biomedicine & Pharmacotherapy

Author:

Yang Chan,Liu Hanyu,Xie Ziyan,Yang Qiangfei,Du Lian,Xie Chunguang

Funder

Sichuan Province Science and Technology Support Program

Shaanxi Administration of Traditional Chinese Medicine

National Natural Science Foundation of China

China Postdoctoral Science Foundation

Sichuan University

Sichuan Provincial Administration of Traditional Chinese Medicine

Publisher

Elsevier BV

Subject

Pharmacology,General Medicine

Reference33 articles.

1. An update on the epidemiology of type 2 diabetes: a global perspective;Tinajero;Endocrinol. Metab. Clin. North Am.,2021

2. Type 2 diabetes;Vijan;Ann. Intern Med,2019

3. Pathophysiology of type 2 diabetes mellitus;Galicia-Garcia;Int J. Mol. Sci.,2020

4. β Cell dysfunction during progression of metabolic syndrome to type 2 diabetes;Hudish;J. Clin. Invest,2019

5. Type 2 diabetes-a matter of beta-cell life and death?;Rhodes;Science,2005

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Alterations of the gut microbiota and metabolites by ShenZhu TiaoPi granule alleviates hyperglycemia in GK rats;Frontiers in Microbiology;2024-08-29

2. Evidence of traditional Chinese medicine for treating type 2 diabetes mellitus: from molecular mechanisms to clinical efficacy;Pharmaceutical Biology;2024-07-19

3. Mechanism of traditional Chinese medicine in elderly diabetes mellitus and a systematic review of its clinical application;Frontiers in Pharmacology;2024-03-06

4. The reporting quality of randomized controlled trials in Chinese herbal medicine (CHM) formulas for diabetes based on the consort statement and its extension for CHM formulas;Frontiers in Pharmacology;2024-01-22

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3